secwatch.observer — SEC 8-K summary
======================================

Issuer:     Accelerate Diagnostics, Inc (—)
CIK:        0000727207
Form:       8-K
Filed at:   2025-08-18T23:59:59+00:00
Accession:  0001104659-25-079855
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.01, 1.03, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Accelerate Diagnostics closes asset sale; Chapter 11 liquidation plan confirmed, equity canceled
--------------------------------------------------------------------------------

- On August 8, 2025, closed sale of certain assets to Indaba Starling (affiliate of Indaba Capital) under amended asset purchase agreement.
- On August 13, 2025, Bankruptcy Court confirmed Second Amended Combined Disclosure Statement and Chapter 11 Plan of Liquidation.
- Plan effective date expected on or about August 18, 2025; all common stock and warrants canceled, holders receive no distribution.
- As of confirmation, company had approximately 25,477,516 shares outstanding with no shares reserved for future issuance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/727207/000110465925079855/0001104659-25-079855-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/727207/000110465925079855/tm2523695d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-079855

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer